Levothyroxine for Metabolic Dysfunction-Associated Steatohepatitis: It Is the Prime Time for Randomized Controlled Trials

Endocrine Practice 2026

View at publisher
Authors: Stergios A. Polyzos, Paul M. Yen, Leonidas H. Duntas
DOI: 10.1016/j.eprac.2026.03.098
Cited by: 1
References: 25

Fields of Study & Subjects

Liver Disease Diagnosis and Treatment Diet Metabolism and Disease Thyroid Disorders and Treatments

Publication details

Journal / source
Endocrine Practice
Publisher
Elsevier BV
Volume
32
Issue
7
Pages
1170–1173
Publication date
30 March 2026
Language
EN